Dosage for eq

In the Heart Protection Study ( HPS ), involving 20,536 patients (age range 40-80 years, 25% women, 97% Caucasians, 3% other races) treated with simvastatin 40 mg/day (n=10,269) or placebo (n=10,267) over a mean of 5 years, only serious adverse reactions and discontinuations due to any adverse reactions were recorded. Discontinuation rates due to adverse reactions were % in patients treated with simvastatin compared with % in patients treated with placebo. The incidence of myopathy / rhabdomyolysis was < % in patients treated with simvastatin.

Dosage for eq

dosage for eq

Media:

dosage for eqdosage for eqdosage for eqdosage for eqdosage for eq

http://buy-steroids.org